Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Glucagon-Like Peptide 1 Receptor Agonist Usage in Type 2 Diabetes in Primary Care for the UK and Beyond: A Narrative Review
Kevin Fernando, Stephen C. Bain, Patrick Holmes, et al.
Diabetes Therapy (2021) Vol. 12, Iss. 9, pp. 2267-2288
Open Access | Times Cited: 11

Showing 11 citing articles:

Clinical Recommendations to Manage Gastrointestinal Adverse Events in Patients Treated with Glp-1 Receptor Agonists: A Multidisciplinary Expert Consensus
Juan José Gorgojo Martínez, Pedro Mezquita‐Raya, Juana Carretero Gómez, et al.
Journal of Clinical Medicine (2022) Vol. 12, Iss. 1, pp. 145-145
Open Access | Times Cited: 101
Continuous glucose monitoring for the routine care of type 2 diabetes mellitus
Ramzi Ajjan, Tadej Battelino, Xavier Cos, et al.
Nature Reviews Endocrinology (2024) Vol. 20, Iss. 7, pp. 426-440
Closed Access | Times Cited: 22
Knowledge, attitude and practice toward liraglutide and semaglutide among endocrinology medical staff
Bingbing Liu, Xueyi Wu, Xiaoying Zou, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Barriers and Strategies to Optimize the Use of Glucagon-Like Peptide 1 Receptor Agonists in People with Type 2 Diabetes and High Cardiovascular Risk or Established Cardiovascular Disease: A Delphi Consensus in Spain
Manuel Botana López, Miguel Camafort, Raquel Campuzano Ruiz, et al.
Advances in Therapy (2024) Vol. 41, Iss. 9, pp. 3569-3584
Open Access | Times Cited: 3
The first successful desensitization protocol in exenatide allergy: a case report
Osman Ozan Yeğit, Göktuğ Sarıbeyliler, Pelin Karadağ, et al.
Allergy Asthma and Clinical Immunology (2023) Vol. 19, Iss. 1
Open Access | Times Cited: 8
Can glucagon-like peptide-1 receptor agonists cause acute kidney injury? An analytical study based on post-marketing approval pharmacovigilance data
Shichao Dong, Chuan Sun
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 11
GLP-1 RAs in Spain: A Short Narrative Review of Their Use in Real Clinical Practice
Irene Romera, Miriam Rubio-de Santos, Sara Artola, et al.
Advances in Therapy (2023) Vol. 40, Iss. 4, pp. 1418-1429
Open Access | Times Cited: 3
Fasting period after Rybelsus administration influences clinical benefit
Hiroshi Bando, Kenji Hayashi, Kazuya Miki, et al.
International Journal of Complementary & Alternative Medicine (2022) Vol. 15, Iss. 3, pp. 151-152
Open Access | Times Cited: 1
AN INSIGHT INTO BIOSIMILARS: RECENT UPDATE AND FUTURE
Dhrubajyoti Sarkar
International Journal of Biology Pharmacy and Allied Sciences (2023) Vol. 12, Iss. 6 (SPECIAL ISSUE)
Open Access
The First Successful Desensitization Protocol in Exenatide Allergy: A Case Report
Osman Ozan Yeğit, Göktuğ Sarıbeyliler, Pelin Karadağ, et al.
Research Square (Research Square) (2022)
Open Access

Kenji Hayashi, Hiroshi Bando, Kazuya Miki, et al.
International Journal of Complementary & Alternative Medicine (2022) Vol. 15, Iss. 3
Open Access
Page 1

Scroll to top